Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice

Abstract Background Symptoms associated with acute pancreatitis can be debilitating, and treatment remains a challenge. This study aimed to investigate the efficacy of selectively inhibiting the soluble form of TNF (solTNF) using the biologic XPro1595 in a mouse model of acute pancreatitis. Methods...

Full description

Bibliographic Details
Main Authors: Rajasa Randhi, Melissa Damon, Kirsty J. Dixon
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-021-01827-0
_version_ 1818937688498110464
author Rajasa Randhi
Melissa Damon
Kirsty J. Dixon
author_facet Rajasa Randhi
Melissa Damon
Kirsty J. Dixon
author_sort Rajasa Randhi
collection DOAJ
description Abstract Background Symptoms associated with acute pancreatitis can be debilitating, and treatment remains a challenge. This study aimed to investigate the efficacy of selectively inhibiting the soluble form of TNF (solTNF) using the biologic XPro1595 in a mouse model of acute pancreatitis. Methods Acute pancreatitis was induced in adult male C57Bl/6J mice by administering cerulein (8 injections of 50 µg/kg I.P., spaced an hour apart), with XPro1595 (10 mg/kg, S.C.) or vehicle being administered approximately 18 h after the last injection. Serum was collected 6 or 18 h after the last cerulein injection, pancreatic tissue was collected 2 and 7 days post-induction, and brain hippocampal tissue was collected at 7 days post-induction. The animal’s pain level was assessed 3, 5 and 7 days post-induction. Results The induction of acute pancreatitis promoted a strong increase in serum amylase levels, which had receded back to baseline levels by the next morning. XPro1595 treatment began after amylase levels had subsided at 18 h, and prevented pancreatic immune cell infiltration, that subsequently prevented tissue disruption and acinar cell death. These improvements in pathology were associated with a significant reduction in mechanical hypersensitivity (neuropathic pain). XPro1595 treatment also prevented an increase in hippocampal astrocyte reactivity, that may be associated with the prevention of neuropathic pain in this mouse model. Conclusion Overall, we observed that selectively inhibiting solTNF using XPro1595 improved the pathophysiological and neurological sequelae of cerulein-induced pancreatitis in mice, which provides support of its use in patients with pancreatitis.
first_indexed 2024-12-20T05:55:56Z
format Article
id doaj.art-ecd3117c6d8240cd955d1dbecc73b8bf
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-20T05:55:56Z
publishDate 2021-05-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-ecd3117c6d8240cd955d1dbecc73b8bf2022-12-21T19:51:02ZengBMCBMC Gastroenterology1471-230X2021-05-0121111010.1186/s12876-021-01827-0Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in miceRajasa Randhi0Melissa Damon1Kirsty J. Dixon2Department of Surgery, Virginia Commonwealth UniversityDepartment of Surgery, Virginia Commonwealth UniversityDepartment of Surgery, Virginia Commonwealth UniversityAbstract Background Symptoms associated with acute pancreatitis can be debilitating, and treatment remains a challenge. This study aimed to investigate the efficacy of selectively inhibiting the soluble form of TNF (solTNF) using the biologic XPro1595 in a mouse model of acute pancreatitis. Methods Acute pancreatitis was induced in adult male C57Bl/6J mice by administering cerulein (8 injections of 50 µg/kg I.P., spaced an hour apart), with XPro1595 (10 mg/kg, S.C.) or vehicle being administered approximately 18 h after the last injection. Serum was collected 6 or 18 h after the last cerulein injection, pancreatic tissue was collected 2 and 7 days post-induction, and brain hippocampal tissue was collected at 7 days post-induction. The animal’s pain level was assessed 3, 5 and 7 days post-induction. Results The induction of acute pancreatitis promoted a strong increase in serum amylase levels, which had receded back to baseline levels by the next morning. XPro1595 treatment began after amylase levels had subsided at 18 h, and prevented pancreatic immune cell infiltration, that subsequently prevented tissue disruption and acinar cell death. These improvements in pathology were associated with a significant reduction in mechanical hypersensitivity (neuropathic pain). XPro1595 treatment also prevented an increase in hippocampal astrocyte reactivity, that may be associated with the prevention of neuropathic pain in this mouse model. Conclusion Overall, we observed that selectively inhibiting solTNF using XPro1595 improved the pathophysiological and neurological sequelae of cerulein-induced pancreatitis in mice, which provides support of its use in patients with pancreatitis.https://doi.org/10.1186/s12876-021-01827-0Acute pancreatitisCeruleinMiceInflammationCytokinesTNF
spellingShingle Rajasa Randhi
Melissa Damon
Kirsty J. Dixon
Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
BMC Gastroenterology
Acute pancreatitis
Cerulein
Mice
Inflammation
Cytokines
TNF
title Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
title_full Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
title_fullStr Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
title_full_unstemmed Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
title_short Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
title_sort selective inhibition of soluble tnf using xpro1595 relieves pain and attenuates cerulein induced pathology in mice
topic Acute pancreatitis
Cerulein
Mice
Inflammation
Cytokines
TNF
url https://doi.org/10.1186/s12876-021-01827-0
work_keys_str_mv AT rajasarandhi selectiveinhibitionofsolubletnfusingxpro1595relievespainandattenuatesceruleininducedpathologyinmice
AT melissadamon selectiveinhibitionofsolubletnfusingxpro1595relievespainandattenuatesceruleininducedpathologyinmice
AT kirstyjdixon selectiveinhibitionofsolubletnfusingxpro1595relievespainandattenuatesceruleininducedpathologyinmice